Abstract
Summary DeepPheWAS is an R package for phenome wide association studies that creates clinically-curated composite phenotypes, and integrates quantitative phenotypes from primary care data, longitudinal trajectories of quantitative measures, disease progression, and drug response phenotypes. Tools are provided for efficient analysis of association with any genetic input, under any genetic model, with optional sex-stratified analysis, and for developing novel phenotypes.
Availability and Implementation The DeepPheWAS R package is freely available under GNU general public licence v3.0 from at https://github.com/Richard-Packer/DeepPheWAS.
Contact richard.packer{at}leicester.ac.uk
Supplementary information Supplementary methods and results are available at Bioinformatics online.
Competing Interest Statement
MDT, RP, ATW, FD and LVW received funding from Orion Pharma within the scope of the submitted work, and from GSK for collaborative research projects outside of the submitted work . WH, BSR, MM, and RB are salaried employees of Orion Pharma within the scope of the submitted work.
Funding Statement
This work is supported by: Orion Pharma funded a research collaboration with the University of Leicester, which supported the development of Deep-PheWAS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank had obtained ethics approval from the North West Multi-centre Research Ethics Committee which covers the UK (approval number: 11/NW/0382) and had obtained informed consent from all participants. The UK Biobank approved an application for use of the data (ID 43027).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
DeepPheWAS is now an R package rather than a pipeline of R scripts. The user guide has also been updated with additional text detailing how to use the R package. the supplementary text has been edited to reflect updates in how the phenotypes are made in the phenotype generation step.
Data Availability
The raw data is available on application to UK Biobank. Scripts to produce the results highlighted here are availble from provided github address.
